Precisely Extends Data Integrity Leadership with New Innovations in First-of-its-Kind Data Integrity Suite
Precisely, the global leader in data integrity, today launched its new Precisely Data Integrity Suite – bringing the latest innovation in data integrity to the market. Announced at the company’s Trust ’22 event, the Data Integrity Suite is composed of seven interoperable SaaS modules that can be deployed individually, or seamlessly combined to deliver exponential value – fuelling businesses with unparalleled levels of trusted data.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220621005275/en/
The Precisely Data Integrity Suite is composed of seven interoperable SaaS modules that can be deployed individually, or seamlessly combined to deliver exponential value - fuelling businesses with unparalleled levels of trusted data. (Graphic: Business Wire)
The announcement comes at the same time as the latest IDC Spotlight paper on “Improving Data Integrity and Trust through Transparency and Enrichment,” shows that only 27% of data professionals say they completely trust their data. With 63% of organizations reporting that higher levels of data integrity make a positive impact on their business metrics 1, the launch of the new Data Integrity Suite is a timely one.
“Data integrity is an imperative for every business, but the journey to achieving it is different for every organization. With the Precisely Data Integrity Suite, businesses can start anywhere, go at their own pace, and grow value at every step of their unique journey,” said Eric Yau, COO at Precisely. “Our unmatched breadth of data integrity capabilities and enrichment data, combined with our strategic services expertise, means that we can help businesses chart their path to data integrity and lead them along the way.”
The Suite’s Data Integration, Data Observability, and Data Governance modules are available for early access now for businesses looking to build a foundation of accuracy and consistency in their data:
-
Data Integration
: enables organizations to break down silos by quickly building streaming data pipelines that integrate data from core transaction systems into modern data platforms, driving innovation, and modernizing mission-critical infrastructure
-
Data Observability
: a new entry from Precisely into this rapidly growing market, proactively and intelligently detects and surfaces data anomalies before they become costly downstream issues that could disrupt business
- Data Governance: delivers a business-friendly framework to find, understand, trust, and leverage critical data across an organization for better outcomes and insights, improved operations, and regulatory compliance
The following modules will join the Data Integrity Suite in the coming months:
-
Data Quality: delivers data that is accurate, consistent, complete, and fit for purpose across operational and analytical systems
-
Geo Addressing: unlocks valuable context by verifying, standardizing, cleansing, and geocoding addresses for more informed decision-making
-
Spatial Analytics: derives and visualizes spatial relationships hidden in data to reveal critical context for better decisions
- Data Enrichment: enriches data with expertly curated datasets containing thousands of attributes for faster, more confident decisions
The Data Integrity Suite delivers access to trusted data at the speed of business and empowers organizations to make fast, confident decisions that drive growth, reduce costs, and manage risk. With a business-friendly user experience, it supports data democratization and self-service access to data for business and data users alike. Its unique Data Integrity Foundation includes a common data catalog that enables each module to build on metadata previously gathered by other modules, combining seamlessly to deliver maximum value to the customer.
“With the launch, Precisely is delivering on the vision they have painted for the market of integrating its capabilities into a modular, interoperable suite,” said Stewart Bond, Research Director at IDC. “Precisely has a strategic blend of technology and services within its portfolio to meet the needs of organizations with legacy and modern data environments that are wanting to compete in a digital-first world.”
“Businesses are increasingly investing in DataOps to continually improve the data they use for analytics and decision-making. The Precisely Data Integrity Suite’s end-to-end, integrated approach to data integration, data governance and quality, as well as location intelligence and data enrichment gives organizations all the tools and agility they need to automate and iterate on the integrity of their data,” said Anjan Kundavaram, CPO at Precisely. “The introduction of the Suite’s Data Observability module is essential for DataOps teams, allowing them to leverage AI and machine learning to gain critical insight into the health of their company’s data, monitor changes to patterns in that data, and proactively resolve potential issues.”
Financial services company, Degroof Petercam, a Precisely customer and participant in the Data Integrity Suite’s early access program, sees clear benefits of the new Data Observability module. “Observability is the missing piece today to give our data stewards access to data discovery insights without having to go to IT for queries or reports.” explains Jean-Paul Otte, Chief Data Officer at Degroof Petercam.
“The portfolio of data integrity assets that Precisely offers is the gold standard for building trusted data,” said Yau. “That same technology, recognized by industry analysts and relied upon by over 12,000 customers to address their data challenges today, is at the heart of the new Precisely Data Integrity Suite – providing the ultimate modular, interoperable, solution for organizations relying on data integrity across both legacy and modern cloud environments.”
Learn more about the new Data Integrity Suite and watch the 90-second video.
Data Integrity Suite Video Embed: <iframe width="560" height="315" src="https://www.youtube.com/embed/0y-YZDoeutc" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
- IDC Spotlight, sponsored by Precisely, “Improving Data Integrity and Trust Through Transparency and Enrichment” (doc # US49285622, June 2022)
About Precisely
Precisely is the global leader in data integrity, providing accuracy, consistency, and context in data for 12,000 customers in more than 100 countries, including 99 of the Fortune 100. Precisely’s data integration, data quality, data governance, location intelligence, and data enrichment products power better business decisions to create better outcomes. Learn more at www.precisely.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220621005275/en/
Contact information
Press Contact
Ned Tadic (US)
Emma Forrest (Europe)
press@precisely.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
